Hormone Therapy Use in Women Veterans Accessing Veterans Health Administration Care: A National Cross-Sectional Study
详细信息    查看全文
  • 作者:Megan R. Gerber MD ; MPH (1) (2)
    Matthew W. King PhD (3) (4)
    Suzanne L. Pineles PhD (3) (4)
    Shannon Wiltsey-Stirman PhD (3) (4)
    Bevanne Bean-Mayberry MD
    ; MHS (5) (6)
    Sandra J. Japuntich PhD (3) (4)
    Sally G. Haskell MD (7) (8)

    1. Women Veterans Program
    ; VA Boston Healthcare System ; 150 S. Huntington Avenue PC11/WHC ; Jamaica Plain ; MA ; Boston ; 02130 ; USA
    2. Department of Medicine
    ; Boston University School of Medicine ; Boston ; MA ; USA
    3. National Center for PTSD
    ; Women鈥檚 Health Sciences Division ; VA Boston Healthcare System ; Jamaica Plain ; Boston ; MA ; USA
    4. Department of Psychiatry
    ; Boston University School of Medicine ; Boston ; MA ; USA
    5. VA Greater Los Angeles Healthcare System
    ; Los Angeles ; CA ; USA
    6. Department of Medicine
    ; UCLA David Geffen School of Medicine ; Los Angeles ; CA ; USA
    7. Department of Medicine
    ; VA Connecticut Healthcare System ; Section of General Internal Medicine ; West Haven ; CT ; USA
    8. Department of Medicine
    ; Section of General Internal Medicine ; Yale University School of Medicine ; New Haven ; CT ; USA
  • 关键词:women Veterans ; hormone therapy ; mental health
  • 刊名:Journal of General Internal Medicine
  • 出版年:2015
  • 出版时间:February 2015
  • 年:2015
  • 卷:30
  • 期:2
  • 页码:169-175
  • 全文大小:219 KB
  • 参考文献:1. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women鈥檚 Health Initiative randomized controlled trial. / JAMA : the journal of the American Medical Association. Jul 17 2002;288(3):321鈥?33.
    2. Haskell SG, Bean-Mayberry B, Goulet JL, Skanderson M, Good CB, Justice AC. Determinants of hormone therapy discontinuation among female veterans nationally. / Military medicine. Jan 2008;173(1):91鈥?6.
    3. Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999鈥?010. / Obstet Gynecol. Sep 2012;120(3):595鈥?03.
    4. The 2012 hormone therapy position statement of: The North American Menopause Society. / Menopause. Mar 2012;19(3):257鈥?71.
    5. Moyer VA. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: U.S. Preventive Services Task Force Recommendation Statement. / Annals of Internal Medicine. 2013;158(1):47鈥?4.
    6. Stuenkel CA, Gass ML, Manson JE, et al. A decade after the Women鈥檚 Health Initiative--the experts do agree. / Menopause. Aug 2012;19(8):846鈥?47.
    7. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women鈥檚 Health Initiative randomized controlled trial. / JAMA : the journal of the American Medical Association. Apr 14 2004;291(14):1701鈥?712.
    8. LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. / JAMA : the Journal of the American Medical Association. Apr 6 2011;305(13):1305鈥?314.
    9. Jungheim ES, Colditz GA. Short-term use of unopposed estrogen: a balance of inferred risks and benefits. / JAMA : the Journal of the American Medical Association. Apr 6 2011;305(13):1354鈥?355.
    10. Ness J, Aronow WS, Newkirk E, McDanel D. Use of hormone replacement therapy by postmenopausal women after publication of the Women鈥檚 Health Initiative Trial. / The journals of gerontology. Series A, Biological sciences and medical sciences. Apr 2005;60(4):460鈥?62.
    11. Ness J, Aronow WS. Prevalence and causes of persistent use of hormone replacement therapy among postmenopausal women: a follow-up study. / American journal of therapeutics. Mar-Apr 2006;13(2):109鈥?12.
    12. Haimov-Kochman R, Barak-Glantz E, Ein-Mor E, et al. Duration not severity of the climacteric syndrome predicts resumption of hormone therapy after discontinuation: a prospective cohort study. / Human reproduction. Sep 2006;21(9):2450鈥?454.
    13. Newton KM, Reed SD, Nekhyludov L, et al. Factors Associated with Successful Discontinuation of Hormone Therapy. J Womens Health (Larchmt). Jan 20 2014.
    14. Dumas JA, Albert KM, Naylor MR, Sites CK, Benkelfat C, Newhouse PA. The effects of age and estrogen on stress responsivity in older women. / The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. Sep 2012;20(9):734鈥?43.
    15. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. / The American journal of psychiatry. Dec 2004;161(12):2238鈥?244.
    16. Toffol E, Heikinheimo O, Partonen T. Associations between psychological well-being, mental health, and hormone therapy in perimenopausal and postmenopausal women: results of two population-based studies. Menopause. Dec 30 2012.
    17. Frayne SM, Phibbs CS, Berg E, et al. / Sourcebook: Women Veterans in the Veterans Health Administration. Volume 2. Sociodemographics and Use of VHA and Non-VA Care (Fee). Washington, D.C.: Women鈥檚 Health Evaluation Initiative, Women鈥檚 Health Services, Veterans Health Administration, Department of Veterans Affairs;2012 (October).
    18. Haskell SG, Bean-Mayberry B, Gordon K. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms? / Menopause. May-Jun 2009;16(3):494鈥?99.
    19. Haskell SG. After the Women鈥檚 Health Initiative: Postmenopausal women鈥檚 experiences with discontinuing estrogen replacement therapy. / J Womens Health (Larchmt). May 2004;13(4):438鈥?42.
    20. Zinzow HM, Grubaugh AL, Monnier J, Suffoletta-Maierle S, Frueh BC. Trauma among female veterans: a critical review. / Trauma Violence Abuse. Oct 2007;8(4):384鈥?00.
    21. Schmidt PJ, Rubinow DR. Sex hormones and mood in the perimenopause. / Annals of the New York Academy of Sciences. Oct 2009;1179:70鈥?5.
    22. Stekhoven DJ, Buhlmann P. MissForest--non-parametric missing value imputation for mixed-type data. / Bioinformatics. Jan 1 2012;28(1):112鈥?18.
    23. Goodman NF, Cobin RH, Ginzburg SB, Katz IA, Woode DE. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause: executive summary of recommendations. / Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. Nov-Dec 2011;17(6):949鈥?54.
    24. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women鈥檚 Health Initiative randomized trials. / JAMA : the journal of the American Medical Association. Oct 2 2013;310(13):1353鈥?368.
    25. de Villiers TJ, Stevenson JC. The WHI: the effect of hormone replacement therapy on fracture prevention. / Climacteric. Jun 2012;15(3):263鈥?66.
    26. Lehavot K, Hoerster KD, Nelson KM, Jakupcak M, Simpson TL. Health indicators for military, veteran, and civilian women. / American journal of preventive medicine. May 2012;42(5):473鈥?80.
    27. Glover EM, Jovanovic T, Mercer KB, et al. Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder. / Biol Psychiatry. Jul 1 2012;72(1):19鈥?4.
    28. Glover EM, Mercer KB, Norrholm SD, et al. Inhibition of fear is differentially associated with cycling estrogen levels in women. / J Psychiatry Neurosci. Apr 23 2013;38(3):120-129.
    29. Lebron-Milad K, Graham BM, Milad MR. Low estradiol levels: a vulnerability factor for the development of posttraumatic stress disorder. / Biol Psychiatry. Jul 1 2012;72(1):6鈥?.
    30. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. / Biol Psychiatry. Nov 1 1998;44(9):839鈥?50.
    31. Lokuge S, Frey BN, Foster JA, Soares CN, Steiner M. Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin. / The Journal of clinical psychiatry. Nov 2011;72(11):e1563-1569.
    32. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. / Menopause. May-Jun 2005;12(3):258鈥?66.
    33. Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women鈥檚 Health across the Nation. / Obstet Gynecol Clin North Am. Sep 2011;38(3):489鈥?01.
    34. Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: who is most bothered by vasomotor symptoms? / Menopause. Sep-Oct 2008;15(5):841鈥?47.
    35. Hunter MS, Chilcot J. Testing a cognitive model of menopausal hot flushes and night sweats. / Journal of psychosomatic research. Apr 2013;74(4):307鈥?12.
    36. Thurston RC, Bromberger J, Chang Y, et al. Childhood abuse or neglect is associated with increased vasomotor symptom reporting among midlife women. / Menopause. Jan-Feb 2008;15(1):16鈥?2.
    37. Kelly UA, Skelton K, Patel M, Bradley B. More than military sexual trauma: interpersonal violence, PTSD, and mental health in women veterans. / Res Nurs Health. Dec 2011;34(6):457鈥?67.
    38. Rasmusson AM, Vythilingam M, Morgan CA, 3rd. The neuroendocrinology of posttraumatic stress disorder: new directions. / CNS Spectr. Sep 2003;8(9):651鈥?56, 665鈥?57.
    39. Suris A, Lind L. Military sexual trauma: a review of prevalence and associated health consequences in veterans. / Trauma Violence Abuse. Oct 2008;9(4):250鈥?69.
    40. Nicolaidis C, Curry M, McFarland B, Gerrity M. Violence, mental health, and physical symptoms in an academic internal medicine practice. / J Gen Intern Med. Aug 2004;19(8):819鈥?27.
    41. Gerber MR, Wittenberg E, Ganz ML, Williams CM, McCloskey LA. Intimate partner violence exposure and change in women鈥檚 physical symptoms over time. / J Gen Intern Med. Jan 2008;23(1):64鈥?9.
    42. Gardella C, Johnson KM, Dobie DJ, Bradley KA. Prevalence of hysterectomy and associated factors in women Veterans Affairs patients. / The Journal of reproductive medicine. Mar 2005;50(3):166鈥?72.
    43. Lamvu G. Role of hysterectomy in the treatment of chronic pelvic pain. / Obstet Gynecol. May 2011;117(5):1175鈥?178.
    44. Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. / BMJ. Apr 1 2006;332(7544):749鈥?55.
    45. Liu CF, Bryson CL, Burgess JF, Jr., Sharp N, Perkins M, Maciejewski ML. Use of outpatient care in VA and Medicare among disability-eligible and age-eligible veteran patients. / BMC Health Serv Res. 2012;12:51.
    46. Kroenke CH, Caan BJ, Stefanick ML, et al. Effects of a dietary intervention and weight change on vasomotor symptoms in the Women鈥檚 Health Initiative. / Menopause. Sep 2012;19(9):980鈥?88.
    47. Das SR, Kinsinger LS, Yancy WS, Jr., et al. Obesity prevalence among veterans at Veterans Affairs medical facilities. / American journal of preventive medicine. Apr 2005;28(3):291鈥?94.
  • 刊物主题:Internal Medicine;
  • 出版者:Springer US
  • ISSN:1525-1497
文摘

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700